U.S. Customs and Border Protection (CBP) reported two recent enforcement actions in posts published on March 31 and April 1, 2026.
On March 31, CBP announced the arrest of a Honduran national by New Orleans Sector Border Patrol Agents. The agency stated: "PREVIOUSLY REMOVED SEX OFFENDER CAUGHT
New Orleans Sector Border Patrol Agents recently arrested this Honduran illegal alien.
Background checks revealed he had previously been removed from the United States, and had been convicted of two counts of child sex abuse in Virginia." This incident highlights ongoing efforts by CBP to apprehend individuals with criminal histories who attempt to re-enter the United States after removal.
On April 1, CBP shared details regarding an intercepted smuggling attempt involving pharmaceuticals. According to the agency's statement: "CBP Mogs Smugglers!
A shipper in China attempted to clandestinely introduce various types of peptides, particularly the active ingredients for Glucagon-like peptide-1, or GLP-1, weight loss drugs into the United States.
Since discovering this scheme, Cincinnati CBP officers" The post refers to attempts to illegally import substances commonly used in certain weight loss medications.
The interception of pharmaceutical shipments at U.S. borders is part of a broader effort by CBP to prevent unapproved drugs from entering domestic markets. In recent years, there has been increased scrutiny over imports containing active ingredients for GLP-1 receptor agonists due to their popularity as weight loss treatments and potential safety risks when obtained outside regulated channels.
These enforcement actions are part of CBP’s mandate to secure U.S. borders against unauthorized entry and illicit trade.
